相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin
M. N. Cruickshank et al.
LEUKEMIA (2017)
MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations
Mark Kerstjens et al.
ONCOTARGET (2017)
The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia
Adele Baker et al.
CANCER RESEARCH (2016)
Menin-MLL inhibitors block oncogenic transformation by MLL-fusion proteins in a fusion partner-independent manner
S. He et al.
LEUKEMIA (2016)
Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia
Seong Lin Khaw et al.
BLOOD (2016)
Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy
Rebecca Gardner et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation
J. Finke et al.
BONE MARROW TRANSPLANTATION (2016)
A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
Todd M. Cooper et al.
CLINICAL CANCER RESEARCH (2016)
Discovery of Novel Inhibitors Targeting the Menin-Mixed Lineage Leukemia Interface Using Pharmacophore- and Docking-Based Virtual Screening
Yuan Xu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
Zizhen Feng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Property Focused Structure-Based Optimization of Small Molecule Inhibitors of the Protein-Protein Interaction between Menin and Mixed Lineage Leukemia (MLL)
Dmitry Borkin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Identification of phenoxyacetamide derivatives as novel DOT1L inhibitors via docking screening and molecular dynamics simulation
Minghao Luo et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2016)
Molecular Coupling of Histone Crotonylation and Active Transcription by AF9 YEATS Domain
Yuanyuan Li et al.
MOLECULAR CELL (2016)
PAX5 promotes pre-B cell proliferation by regulating the expression of pre-B cell receptor and its downstream signaling
Kai Xue et al.
MOLECULAR IMMUNOLOGY (2016)
Structural basis for activity regulation of MLL family methyltransferases
Yanjing Li et al.
NATURE (2016)
Functional interdependence of BRD4 and DOT1L in MLL leukemia
Omer Gilan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Lineage Switch in MLL-Rearranged Infant Leukemia Following CD19-Directed Therapy
Ahmad Rayes et al.
PEDIATRIC BLOOD & CANCER (2016)
ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia
Li Zhu et al.
CANCER DISCOVERY (2016)
Functional interdependence of BRD4 and DOT1L in MLL leukemia
Omer Gilan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways
Rolf Marschalek
ANNALS OF LABORATORY MEDICINE (2016)
Leukemogenic MLL-ENL Fusions Induce Alternative Chromatin States to Drive a Functionally Dichotomous Group of Target Genes
Maria-Paz Garcia-Cuellar et al.
CELL REPORTS (2016)
Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials
Seongseok Yun et al.
CLINICAL EPIGENETICS (2016)
Maintenance of leukemic cell identity by the activity of the Polycomb complex PRC1 in mice
Alessandra Rossi et al.
SCIENCE ADVANCES (2016)
The essential role of acetyllysine binding by the YEATS domain in transcriptional regulation
Forest H. Andrews et al.
TRANSCRIPTION-AUSTIN (2016)
Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies
Geoffrey M. Matthews et al.
BLOOD (2015)
Subclonality and prenatal origin of RAS mutations in KMT2A (MLL)-rearranged infant acute lymphoblastic leukaemia
Mariana Emerenciano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia
Elias Jabbour et al.
CANCER (2015)
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
Sarah Picaud et al.
CANCER RESEARCH (2015)
Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL
Matthew C. Stubbs et al.
CLINICAL CANCER RESEARCH (2015)
The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia
Dominique J. P. M. Stumpel et al.
EUROPEAN JOURNAL OF CANCER (2015)
Inactivation of Eed impedes MLL-AF9-mediated leukemogenesis through Cdkn2a-dependent and Cdkn2a-independent mechanisms in a murine model
Etienne Danis et al.
EXPERIMENTAL HEMATOLOGY (2015)
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
C. Michel Zwaan et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The PZP Domain of AF10 Senses Unmodified H3K27 to Regulate DOT1L-Mediated Methylation of H3K79
Shoudeng Chen et al.
MOLECULAR CELL (2015)
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias
Anna K. Andersson et al.
NATURE GENETICS (2015)
The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias
Vincent-Philippe Lavallee et al.
NATURE GENETICS (2015)
DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia
Chun-Wei Chen et al.
NATURE MEDICINE (2015)
Acute Lymphoblastic Leukemia in Children
Stephen P. Hunger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
AF4 uses the SL1 components of RNAP1 machinery to initiate MLL fusion- and AEP-dependent transcription
Hiroshi Okuda et al.
NATURE COMMUNICATIONS (2015)
MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199
Juliana M. Benito et al.
CELL REPORTS (2015)
Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia
Bowen Xu et al.
BLOOD (2015)
Intensified Chemotherapy Without Sct in Infant All: Results From COG P9407 (Cohort 3)
ZoAnn E. Dreyer et al.
PEDIATRIC BLOOD & CANCER (2015)
MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia
Elena Manara et al.
BLOOD (2014)
Requirement for CDK6 in MLL-rearranged acute myeloid leukemia
Theresa Placke et al.
BLOOD (2014)
Proteasome Inhibitors Evoke Latent Tumor Suppression Programs in Pro-B MLL Leukemias through MLL-AF4
Han Liu et al.
CANCER CELL (2014)
AF10 Regulates Progressive H3K79 Methylation and HOX Gene Expression in Diverse AML Subtypes
Aniruddha J. Deshpande et al.
CANCER CELL (2014)
Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16
Koki Ueda et al.
CANCER SCIENCE (2014)
AF9 YEATS Domain Links Histone Acetylation to DOT1L-Mediated H3K79 Methylation
Yuanyuan Li et al.
CELL (2014)
MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL
Marieke H. van der Linden et al.
CELL CYCLE (2014)
Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells
Katarzyna Lubecka-Pietruszewska et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
FISH analysis of MLL gene rearrangements: detection of the concurrent loss or gain of the 3′ signal and its prognostic significance
J. -H. Lim et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2014)
Loss of TBL1XR1 Disrupts Glucocorticoid Receptor Recruitment to Chromatin and Results in Glucocorticoid Resistance in a B-Lymphoblastic Leukemia Model
Courtney L. Jones et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity
Yuki Kagoya et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Excess congenital non-synonymous variation in leukemia-associated genes in MLL - infant leukemia: a Children's Oncology Group report
M. C. Valentine et al.
LEUKEMIA (2014)
Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML
K. R. Kampen et al.
LEUKEMIA (2014)
The Histone Methyltransferase Activity of MLL1 Is Dispensable for Hematopoiesis and Leukemogenesis
Bibhu P. Mishra et al.
CELL REPORTS (2014)
Inhibition of class I HDACs abrogates the dominant effect of MLL-AF4 by activation of wild-type MLL
K. Ahmad et al.
ONCOGENESIS (2014)
The biology and targeting of FLT3 in pediatric leukemia
Colleen E. Annesley et al.
FRONTIERS IN ONCOLOGY (2014)
DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
Christine R. Klaus et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
Scott R. Daigle et al.
BLOOD (2013)
Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia
Karen A. Urtishak et al.
BLOOD (2013)
The distribution of MLL breakpoints correlates with outcome in infant acute leukaemia
Mariana Emerenciano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Epigenetic Roles of MLL Oncoproteins Are Dependent on NF-κB
Hsu-Ping Kuo et al.
CANCER CELL (2013)
The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial
David I. Marks et al.
HAEMATOLOGICA (2013)
Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants
Emma M. C. Driessen et al.
HAEMATOLOGICA (2013)
Differential mRNA Expression Levels of Human Histone-Modifying Enzymes in Normal Karyotype B Cell Pediatric Acute Lymphoblastic Leukemia
Yan-Fang Tao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms
Kerstin Maria Kampa-Schittenhelm et al.
MOLECULAR CANCER (2013)
Cell of origin determines clinically relevant subtypes of MLL-rearranged AML
A. V. Krivtsov et al.
LEUKEMIA (2013)
The expression of histone deacetylase 4 is associated with prednisone poor-response in childhood acute lymphoblastic leukemia
Bernd Gruhn et al.
LEUKEMIA RESEARCH (2013)
Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer
Woojin Kim et al.
NATURE CHEMICAL BIOLOGY (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;NrasG12D acute myeloid leukemia
J. Shi et al.
ONCOGENE (2013)
Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia
Eric Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex Interaction
Adam C. Wilkinson et al.
CELL REPORTS (2013)
MLL-ENL Inhibits Polycomb Repressive Complex 1 to Achieve Efficient Transformation of Hematopoietic Cells
Emanuel Maethner et al.
CELL REPORTS (2013)
The Pathogenesis of Mixed-Lineage Leukemia
Andrew G. Muntean et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs
Eric M. J. Bindels et al.
BLOOD (2012)
Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia
Teena Bhatla et al.
BLOOD (2012)
The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
William J. Harris et al.
CANCER CELL (2012)
Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
Alexei F. Kisselev et al.
CHEMISTRY & BIOLOGY (2012)
Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia
D. J. P. M. Stumpel et al.
LEUKEMIA (2012)
Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+and MLL-germline acute lymphoblastic leukemia
M. C. Chillon et al.
LEUKEMIA (2012)
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia
Jolanta Grembecka et al.
NATURE CHEMICAL BIOLOGY (2012)
Polycomb repressive complex 2 is required for MLL-AF9 leukemia
Tobias Neff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
MLL-aberrant leukemia: complete cytogenetic remission following treatment with a histone deacetylase inhibitor (HDACi)
Kate L. Burbury et al.
ANNALS OF HEMATOLOGY (2011)
Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation
Stephanie Y. Jo et al.
BLOOD (2011)
DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis
Anh Tram Nguyen et al.
BLOOD (2011)
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Kathrin M. Bernt et al.
CANCER CELL (2011)
CBX8, a Polycomb Group Protein, Is Essential for MLL-AF9-Induced Leukemogenesis
Jiaying Tan et al.
CANCER CELL (2011)
Functional Crosstalk between Bmi1 and MLL/Hoxa9 Axis in Establishment of Normal Hematopoietic and Leukemic Stem Cells
Lan-Lan Smith et al.
CELL STEM CELL (2011)
Proteolytically cleaved MLL subunits are susceptible to distinct degradation pathways
Akihiko Yokoyama et al.
JOURNAL OF CELL SCIENCE (2011)
Analysis of the Role of Hematopoietic Stem-Cell Transplantation in Infants With Acute Lymphoblastic Leukemia in First Remission and MLL Gene Rearrangements: A Report From the Children's Oncology Group
Zoann E. Dreyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells
J. Yuan et al.
LEUKEMIA (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Trithorax group proteins: switching genes on and keeping them active
Bernd Schuettengruber et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes
Debabrata Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin
Nanhai He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Acute Myeloid Leukemia With t(9;11)(p21-22;q23) Common Properties of Dysregulated Ras Pathway Signaling and Genomic Progression Characterize De Novo and Therapy-Related Cases
Pranil Chandra et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia
Mark R. Litzow et al.
BLOOD (2010)
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study
Georg Mann et al.
BLOOD (2010)
Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting
Eric Schafer et al.
BLOOD (2010)
Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia
Daniel Antunes Moreno et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
A Higher-Order Complex Containing AF4 and ENL Family Proteins with P-TEFb Facilitates Oncogenic and Physiologic MLL-Dependent Transcription
Akihiko Yokoyama et al.
CANCER CELL (2010)
MLL-AF9-Induced Leukemogenesis Requires Coexpression of the Wild-Type Mll Allele
Austin T. Thiel et al.
CANCER CELL (2010)
Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
Ming-Jin Chang et al.
CANCER RESEARCH (2010)
Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom)
Man Mohan et al.
GENES & DEVELOPMENT (2010)
Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
Teppei Yamaguchi et al.
GENES & DEVELOPMENT (2010)
Multiple Interactions Recruit MLL1 and MLL1 Fusion Proteins to the HOXA9 Locus in Leukemogenesis
Thomas A. Milne et al.
MOLECULAR CELL (2010)
AFF4, a Component of the ELL/P-TEFb Elongation Complex and a Shared Subunit of MLL Chimeras, Can Link Transcription Elongation to Leukemia
Chengqi Lin et al.
MOLECULAR CELL (2010)
HOXA9 is required for survival in human MLL-rearranged acute leukemias
Joerg Faber et al.
BLOOD (2009)
Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options
Dominique J. P. M. Stumpel et al.
BLOOD (2009)
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol
Marieke H. van der Linden et al.
BLOOD (2009)
Menin regulates the function of hematopoietic stem cells and lymphoid progenitors
I. Maillard et al.
BLOOD (2009)
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
Patrick P. Zarrinkar et al.
BLOOD (2009)
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
Brian V. Balgobind et al.
BLOOD (2009)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Consistent Deregulation of Gene Expression between Human and Murine MLL Rearrangement Leukemias
Zejuan Li et al.
CANCER RESEARCH (2009)
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol
V. H. J. Van der Velden et al.
LEUKEMIA (2009)
Outcome of Recurrent or Refractory Acute Lymphoblastic Leukemia in Infants With MLL Gene Rearrangements: A Report From the Japan Infant Leukemia Study Group
Daisuke Tomizawa et al.
PEDIATRIC BLOOD & CANCER (2009)
Misguided Transcriptional Elongation Causes Mixed Lineage Leukemia
Dorothee Mueller et al.
PLOS BIOLOGY (2009)
Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia
Tanzina Chowdhury et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation
Blaine W. Robinson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Menin critically links MLL proteins with LEDGE on cancer-associated target genes
Akihiko Yokoyama et al.
CANCER CELL (2008)
H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
Andrei V. Krivtsov et al.
CANCER CELL (2008)
Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia
Junping Wei et al.
CANCER CELL (2008)
Loss of MLL PHD finger 3 is necessary for MLL-ENL-induced hematopoietic stem cell immortalization
Jing Chen et al.
CANCER RESEARCH (2008)
MLLT3 regulates early human erythroid and megakaryocytic cell fate
Cristina Pina et al.
CELL STEM CELL (2008)
Clinical features and outcome of MLL gene rearranged acute lymphoblastic leukemia in infants with additional chromosomal abnormalities other than 11q23 translocation
Hisamichi Tauchi et al.
LEUKEMIA RESEARCH (2008)
Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation
Robert K. McGinty et al.
NATURE (2008)
MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment
M. C. Stubbs et al.
LEUKEMIA (2008)
A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification
Dorothee Mueller et al.
BLOOD (2007)
Acute lymphoblastic leukemia in infancy
Lewis B. Silverman
PEDIATRIC BLOOD & CANCER (2007)
Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential
Piu Wong et al.
GENES & DEVELOPMENT (2007)
Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: A final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group
D. Tomizawa et al.
LEUKEMIA (2007)
Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia
Ronald W. Stam et al.
BLOOD (2007)
MII has a critical role in fetal and adult hematopoietic stem cell self-renewal
Kathryn A. McMahon et al.
CELL STEM CELL (2007)
Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors
Craig D. Jude et al.
CELL STEM CELL (2007)
Dietary flavonoids induce MLL translocations in primary human CD34+cells
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani et al.
CARCINOGENESIS (2007)
Interaction of MLL amino terminal sequences with menin is required for transformation
Corrado Caslini et al.
CANCER RESEARCH (2007)
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial
Rob Pieters et al.
LANCET (2007)
Combined effects of the two reciprocal t(4; II) fusion proteins MLL . AF4 and AF4 . MLL confer resistance to apoptosis, cell cycling capacity and growth transformation
A. Gaussmann et al.
ONCOGENE (2007)
Transcription linked to recombination:: a gene-internal promoter coincides with the recombination hot spot II of the human MLL gene
S. Scharf et al.
ONCOGENE (2007)
The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling
Emmanuelle Bitoun et al.
HUMAN MOLECULAR GENETICS (2007)
Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand:: a possible mechanism for poor sensitivity to antitumor immunity
T. Inukai et al.
LEUKEMIA (2006)
The MLL partial tandem duplication in acute myeloid leukaemia
Jorg Basecke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Chromatin structural elements and chromosomal translocations in leukemia
Yanming Zhang et al.
DNA REPAIR (2006)
Controlling the elongation phase of transcription with P-TEFb
B. Matija Peterlin et al.
MOLECULAR CELL (2006)
Combinations of the FLT3 inhibitor CEP-701 and chemotherapy synergistically kill infant and childhood MLL-rearranged ALL cells in a sequence-dependent manner
P. Brown et al.
LEUKEMIA (2006)
Regulation of MLL1 H3K4 methyltransferase activity by its core components
Yali Dou et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group
Joanne M. Hilden et al.
BLOOD (2006)
G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is p21 dependent and MLL-AF9 independent
R. Tonelli et al.
LEUKEMIA (2006)
The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression
YX Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cleavage of the MLL gene by activators of apoptosis is independent of topoisomerase II activity
CJ Betti et al.
LEUKEMIA (2005)
The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis
A Yokoyama et al.
CELL (2005)
MLL associates specifically with a subset of transcriptionally active target genes
TA Milne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia
RW Stam et al.
BLOOD (2005)
Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis
LF Drynan et al.
EMBO JOURNAL (2005)
The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin
DT Zeisig et al.
ONCOGENE (2005)
The MLL partial tandem duplication:: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy
SP Whitman et al.
BLOOD (2005)
Global and Hox-specific roles for the MLL1 methyltransferase
MG Guenther et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
hDOT1L links histone methylation to leukemogenesis
Y Okada et al.
CELL (2005)
The robotic mouse: Unravelling the function of AF4 in the cerebellum
E Bitoun et al.
CEREBELLUM (2005)
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors
TA Milne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression
P Brown et al.
BLOOD (2005)
Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9
CW So et al.
BLOOD (2004)
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype
NL Ramakers-van Woerden et al.
LEUKEMIA (2004)
Menin associates with a trithorax family histone methyltransferase complex and with the Hoxc8 locus
CM Hughes et al.
MOLECULAR CELL (2004)
Adult de novo acute myeloid leukemia with t(6;11)(q27;q23) -: Results from cancer and leukemia group B study 8461 and review of the literature
W Blum et al.
CANCER (2004)
MLL fusion partners AF4 and AF9 interact at subnuclear foci
F Erfurth et al.
LEUKEMIA (2004)
Taspase1:: A threonine aspartase required for cleavage of MLL and proper HOX gene expression
JJD Hsieh et al.
CELL (2003)
Dimerization of MLL fusion proteins immortalizes hematopoietic cells
ME Martin et al.
CANCER CELL (2003)
Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias
CW So et al.
CANCER CELL (2003)
Expression profiles. of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements
T Rozovskaia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor
RS Srinivasan et al.
ONCOGENE (2003)
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements
CH Pui et al.
LEUKEMIA (2003)
Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia
RW Stam et al.
BLOOD (2003)
Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification
SA Armstrong et al.
CANCER CELL (2003)
The effects of cladribine and fludarabine on DNA methylation in K562 cells
D Wyczechowska et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization
JJD Hsieh et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
MLL targets SET domain methyltransferase activity to Hox gene promoters
TA Milne et al.
MOLECULAR CELL (2002)
Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with AF9 after chromosomal translocation in leukemia
EC Collins et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia
ARM von Bergh et al.
GENES CHROMOSOMES & CANCER (2002)
Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics:: A study of the acute myeloid leukemia study group Ulm
K Döhner et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region
CH Pui et al.
LANCET (2002)
Favorable impact of the t(9;11) in childhood acute myeloid leukemia
JE Rubnitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999
JM Chessells et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation
M Birke et al.
NUCLEIC ACIDS RESEARCH (2002)
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
SA Armstrong et al.
NATURE GENETICS (2002)
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
EJ Yeoh et al.
CANCER CELL (2002)
Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem:: report on two new cases and review of the literature since 1992
MK Andersen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia
JG Blanco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The polycomb protein MPc3 interacts with AF9, an MLL fusion partner in t(9;11)(p22;q23) acute leukemias
CS Hemenway et al.
ONCOGENE (2001)
Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL
M Reichel et al.
ONCOGENE (2001)
MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein
P Ernst et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein recruits human Polycomb 3
MP García-Cuéllar et al.
ONCOGENE (2001)
Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia
S Meshinchi et al.
BLOOD (2001)
Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia
R Strick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Tumorigenesis in mice with a fusion of the leukaemia oncogene MII and the bacterial lacZ gene
CL Dobson et al.
EMBO JOURNAL (2000)
DNA methyltransferase Dnmt1 associates with histone deacetylase activity
F Fuks et al.
NATURE GENETICS (2000)
分享论文
